

%201.webp)


%201.webp)




LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。



%201.webp)


%201.webp)




序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

Egypt has implemented a national pharmaceutical traceability framework to improve medicine supply chain transparency and combat counterfeit products. The system is managed through the Egyptian Drug Authority (EDA) under the Ministry of Health.
Egypt’s traceability framework is built around the Egyptian Drug Tracking System (EDTS), which requires pharmaceutical products to carry GS1 compliant DataMatrix barcodes with serialized identifiers. The system enables tracking of medicines from manufacturers and importers through distribution to pharmacies.
The EDTS platform supports digital verification of medicines and helps regulators monitor product movement across the pharmaceutical supply chain. Serialization and traceability requirements apply primarily to human prescription medicines, with implementation occurring in phases.
Pharmaceutical products distributed in Egypt must include a 2D DataMatrix barcode on the secondary packaging.
The barcode must follow GS1 standards and include the following elements:
These data elements allow unique identification of each medicine package and support verification through the national tracking system.
Human readable information printed on the packaging must correspond to the encoded barcode data.
2017
Egypt began developing a national pharmaceutical track and trace strategy to combat counterfeit medicines.
2019
The Egyptian Drug Authority introduced initial serialization and traceability requirements.
2020 onward
Implementation of the Egyptian Drug Tracking System (EDTS) began, enabling serialized identification and verification of medicines.
Current Status
Serialization and traceability requirements are actively being implemented across the pharmaceutical supply chain.
Supply chain actors are responsible for ensuring that serialization data is accurately recorded and reported through the EDTS system.
Traceability reporting in Egypt is conducted through the Egyptian Drug Tracking System (EDTS) operated by the Egyptian Drug Authority.
The system allows pharmaceutical supply chain participants to submit serialization data and track product movement through electronic reporting mechanisms.
Participants interacting with the system include:
The EDTS platform supports:
Egypt’s traceability system focuses primarily on unit level serialization using DataMatrix barcodes.
Aggregation at case or pallet level is not currently mandated in publicly available regulatory guidance. However, many manufacturers implement internal aggregation processes to support logistics operations and facilitate distribution reporting.
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.